New pill could ease vulvodynia pain in minutes
NCT ID NCT07391241
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a single dose of the experimental drug pudafensine in 24 women with provoked vestibulodynia, a type of vulvodynia. Researchers measure pain threshold in the vaginal area to see if the drug reduces sensitivity. The trial is double-blind and placebo-controlled to ensure reliable results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pudafensine
- What this could lead to
- If it works, this could point toward a new, fast-acting pain reliever for women with vulvodynia.
- What could go wrong
- This is a small, early-phase trial with only 24 participants and a single dose. Results may not confirm lasting benefit or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVODYNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MAC
RECRUITINGBlackpool, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new approach to vulvar pain: could education and behavior change bring relief?
- Could a laser ease painful sex for millions of women?
- New hope for Women's pelvic pain: light and physiotherapy put to the test
- Could sound waves soothe a painful condition? new study tests shock therapy for vulvodynia
- Could a simple cream ease chronic pelvic pain?
- Hormone combo may offer new hope for vulvodynia sufferers